Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Phase 1 cancer clinical trials are more beneficial for participants than they used to be, says Naoko Takebe, MD, PhD.
After three surgeries, chemo and radiation, actress Blythe Danner—mom to Gwyneth Paltrow—says, “I’m fine and dandy now.”
Advocates push for increased federal cancer research funding among list of essential cancer priorities
$73,812 for the two shots ($35,414 for the first, $38,398 for the second), including lab work and physician charges.
Governor approves bill to improve health care delivery in PA, enabling cancer patients to receive quicker access to lifesaving treatment
Elahere, a new antibody-drug conjugate, shrank tumors in about a third of treatment-experienced patients.
The checkpoint inhibitor is now approved for people with advanced non-small-cell lung cancer regardless of PD-L1 biomarker levels.
Women were more likely to feel they had to “prove” their symptoms
Metastatic colorectal cancer is on the rise among those under 50. Doctors must not dismiss young people who come to them with symptoms.
Imjudo plus Imfinzi improved overall survival compared with standard targeted therapy for hepatocellular carcinoma.
Expert panel recommends complementary approaches including acupuncture, yoga and massage, but more research is needed.
Black women were more likely to benefit than white women if treated at an earlier disease stage but less likely at a later stage.
Substituting generic, biosimilar or less expensive medications can reduce costs without sacrificing quality of care.
Limiting blood flow to the hands during chemotherapy administration may reduce this common side effect.
Basic, translational and clinical research improves, extends and saves lives.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.